|
1
|
Li JP, Kuo YC, Liao WN, Yang YT, Chen SY, Chien YT, Wu KH, Wang MY, Chou FI, Yang MH, Hueng DY, Yang CS, Chen JK. Harnessing Nuclear Energy to Gold Nanoparticles for the Concurrent Chemoradiotherapy of Glioblastoma. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:2821. [PMID: 37947667 PMCID: PMC10650840 DOI: 10.3390/nano13212821] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/28/2023] [Revised: 06/26/2023] [Accepted: 09/27/2023] [Indexed: 11/12/2023]
Abstract
Nuclear fission reactions can release massive amounts of energy accompanied by neutrons and γ photons, which create a mixed radiation field and enable a series of reactions in nuclear reactors. This study demonstrates a one-pot/one-step approach to synthesizing radioactive gold nanoparticles (RGNP) without using radioactive precursors and reducing agents. Trivalent gold ions are reduced into gold nanoparticles (8.6-146 nm), and a particular portion of 197Au atoms is simultaneously converted to 198Au atoms, rendering the nanoparticles radioactive. We suggest that harnessing nuclear energy to gold nanoparticles is feasible in the interests of advancing nanotechnology for cancer therapy. A combination of RGNP applied through convection-enhanced delivery (CED) and temozolomide (TMZ) through oral administration demonstrates the synergistic effect in treating glioblastoma-bearing mice. The mean survival for RGNP/TMZ treatment was 68.9 ± 9.7 days compared to that for standalone RGNP (38.4 ± 2.2 days) or TMZ (42.8 ± 2.5 days) therapies. Based on the verification of bioluminescence images, positron emission tomography, and immunohistochemistry inspection, the combination treatment can inhibit the proliferation of glioblastoma, highlighting the niche of concurrent chemoradiotherapy (CCRT) attributed to RGNP and TMZ.
Collapse
Affiliation(s)
- Jui-Ping Li
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Yu-Cheng Kuo
- Department of Radiation Oncology, China Medical University Hospital, Taichung 40447, Taiwan;
- School of Medicine, China Medical University, Taichung 40402, Taiwan
| | - Wei-Neng Liao
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Ya-Ting Yang
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Sih-Yu Chen
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Yu-Ting Chien
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Kuo-Hung Wu
- Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan; (K.-H.W.); (M.-Y.W.); (F.-I.C.)
| | - Mei-Ya Wang
- Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan; (K.-H.W.); (M.-Y.W.); (F.-I.C.)
| | - Fong-In Chou
- Nuclear Science and Technology Development Center, National Tsing Hua University, Hsinchu 30013, Taiwan; (K.-H.W.); (M.-Y.W.); (F.-I.C.)
| | - Mo-Hsiung Yang
- Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, Hsinchu 30013, Taiwan;
| | - Dueng-Yuan Hueng
- School of Medicine, National Defense Medical Center, Taipei 11490, Taiwan;
| | - Chung-Shi Yang
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
| | - Jen-Kun Chen
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Miaoli 35053, Taiwan; (J.-P.L.); (W.-N.L.); (Y.-T.Y.); (S.-Y.C.); (Y.-T.C.); (C.-S.Y.)
- Biotechnology Center, National Chung Hsing University, Taichung 40227, Taiwan
- Graduate Institute of Life Sciences, National Defense Medical Center, Taipei 11490, Taiwan
| |
Collapse
|
|
2
|
Daems N, Michiels C, Lucas S, Baatout S, Aerts A. Gold nanoparticles meet medical radionuclides. Nucl Med Biol 2021; 100-101:61-90. [PMID: 34237502 DOI: 10.1016/j.nucmedbio.2021.06.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/02/2021] [Revised: 05/25/2021] [Accepted: 06/04/2021] [Indexed: 12/15/2022]
Abstract
Thanks to their unique optical and physicochemical properties, gold nanoparticles have gained increased interest as radiosensitizing, photothermal therapy and optical imaging agents to enhance the effectiveness of cancer detection and therapy. Furthermore, their ability to carry multiple medically relevant radionuclides broadens their use to nuclear medicine SPECT and PET imaging as well as targeted radionuclide therapy. In this review, we discuss the radiolabeling process of gold nanoparticles and their use in (multimodal) nuclear medicine imaging to better understand their specific distribution, uptake and retention in different in vivo cancer models. In addition, radiolabeled gold nanoparticles enable image-guided therapy is reviewed as well as the enhancement of targeted radionuclide therapy and nanobrachytherapy through an increased dose deposition and radiosensitization, as demonstrated by multiple Monte Carlo studies and experimental in vitro and in vivo studies.
Collapse
Affiliation(s)
- Noami Daems
- Radiobiology Research Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre (SCK CEN), Boeretang 200, 2400 Mol, Belgium.
| | - Carine Michiels
- Unité de Recherche en Biologie Cellulaire-NARILIS, University of Namur, Rue de Bruxelles 61, 5000 Namur, Belgium
| | - Stéphane Lucas
- Laboratory of Analysis by Nuclear Reaction (LARN)-NARILIS, University of Namur, Rue de Bruxelles 61, 5000 Namur, Belgium
| | - Sarah Baatout
- Radiobiology Research Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre (SCK CEN), Boeretang 200, 2400 Mol, Belgium
| | - An Aerts
- Radiobiology Research Unit, Interdisciplinary Biosciences, Institute for Environment, Health and Safety, Belgian Nuclear Research Centre (SCK CEN), Boeretang 200, 2400 Mol, Belgium
| |
Collapse
|
|
3
|
Roki N, Solomon M, Casta L, Bowers J, Getts RC, Muro S. A method to improve quantitative radiotracing-based analysis of the in vivo biodistribution of drug carriers. Bioeng Transl Med 2021; 6:e10208. [PMID: 34027094 PMCID: PMC8126812 DOI: 10.1002/btm2.10208] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2020] [Revised: 11/27/2020] [Accepted: 11/29/2020] [Indexed: 11/20/2022] Open
Abstract
Biodistribution studies are essential in drug carrier design and translation, and radiotracing provides a sensitive quantitation for this purpose. Yet, for biodegradable formulations, small amounts of free-label signal may arise prior to or immediately after injection in animal models, causing potentially confounding biodistribution results. In this study, we refined a method to overcome this obstacle. First, we verified free signal generation in animal samples and then, mimicking it in a controllable setting, we injected mice intravenously with a radiolabeled drug carrier formulation (125I-antibody/3DNA) containing a known amount of free radiolabel (125I), or free 125I alone as a control. Corrected biodistribution data were obtained by separating the free radiolabel from blood and organs postmortem, using trichloroacetic acid precipitation, and subtracting the confounding signal from each tissue measurement. Control free 125I-radiolabel was detected at ≥85% accuracy in blood and tissues, validating the method. It biodistributed very heterogeneously among organs (0.6-39 %ID/g), indicating that any free 125I generated in the body or present in an injected formulation cannot be simply corrected to the free-label fraction in the original preparation, but the free label must be empirically measured in each organ. Application of this method to the biodistribution of 125I-antibody/3DNA, including formulations directed to endothelial target ICAM-1, showed accurate classification of free 125I species in blood and tissues. In addition, this technique rendered data on the in vivo degradation of the traced agents over time. Thus, this is a valuable technique to obtain accurate measurements of biodistribution using 125I and possibly other radiotracers.
Collapse
Affiliation(s)
- Nikša Roki
- Fischell Department of BioengineeringUniversity of MarylandCollege ParkMarylandUSA
- Institute for Bioscience and Biotechnology Research, University of MarylandCollege ParkMarylandUSA
| | - Melani Solomon
- Institute for Bioscience and Biotechnology Research, University of MarylandCollege ParkMarylandUSA
| | - Lou Casta
- Genisphere, LLCHatfieldPennsylvaniaUSA
| | | | - Robert C. Getts
- Genisphere, LLCHatfieldPennsylvaniaUSA
- Present address:
Code Biotherapeutics, Hatfield, PennsylvaniaUSA
| | - Silvia Muro
- Institute for Bioscience and Biotechnology Research, University of MarylandCollege ParkMarylandUSA
- Institute for Bioengineering of Catalonia of the Barcelona Institute of Science and TechnologyBarcelonaSpain
- Institution of Catalonia for Research and Advanced StudiesBarcelonaSpain
| |
Collapse
|
|
4
|
Rasekholghol A, Fazaeli Y, Moradi Dehaghi S, Ashtari P, Kardan M, Feizi S, Samiee Matin M. CdTe quantum dots on gold-198 nano particles: introducing a novel theranostic agent. RADIOCHIM ACTA 2020. [DOI: 10.1515/ract-2020-0047] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Abstract
The influence of coating a CdTe quantum dots (QDs) layer on the 198Au nanoparticles (NPs) in biodistribution of 198Au nanoparticles was investigated. The 198Au nanoparticles were prepared by irradiating the highly pure metallic gold in Tehran research nuclear reactor and subsequently 198Au-NPs were synthesized and subjected to surface modification with cysteamine and CdTe QDs to form an adduct. The prepared nanomaterials were characterized with X-ray diffraction, radio thin layer chromatography, transmission electron microscopy, and scanning electron microscopy. In-vivo biodistribution and tumor avidity studies were performed by intravenously injecting of cysteamine@198AuNPs: CdTe QDs nanocomposite into rats. The %ID/g (percent of the initial dose per gram tissue weight) in dissected organs and Fibrosarcoma tumor specimens was then measured. The hydrophilicity of the cysteamine@198AuNPs was increased by surface modification with CdTe QDs. Rapid excretion from body and high tumor uptake for cysteamine@198AuNPs: CdTe QDs revealed that this radiotracer could potentially be used in nuclear medicine as a theranostic agent.
Collapse
Affiliation(s)
- Ariam Rasekholghol
- Department of Chemistry , Islamic Azad University , Tehran North Branch , Tehran , Islamic Republic of Iran
| | - Yousef Fazaeli
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI) , Moazzen Blvd., Rajaeeshahr , P.O. Box 31485-498 , Karaj , Islamic Republic of Iran
| | - Shahram Moradi Dehaghi
- Department of Chemistry , Islamic Azad University , Tehran North Branch , Tehran , Islamic Republic of Iran
| | - Parviz Ashtari
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI) , Moazzen Blvd., Rajaeeshahr , P.O. Box 31485-498 , Karaj , Islamic Republic of Iran
| | - Mohammadreza Kardan
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI) , Moazzen Blvd., Rajaeeshahr , P.O. Box 31485-498 , Karaj , Islamic Republic of Iran
| | - Shahzad Feizi
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI) , Moazzen Blvd., Rajaeeshahr , P.O. Box 31485-498 , Karaj , Islamic Republic of Iran
| | - Milad Samiee Matin
- Radiation Application Research School, Nuclear Science and Technology Research Institute (NSTRI) , Moazzen Blvd., Rajaeeshahr , P.O. Box 31485-498 , Karaj , Islamic Republic of Iran
| |
Collapse
|
|
5
|
Chen TY, Chen MR, Liu SW, Lin JY, Yang YT, Huang HY, Chen JK, Yang CS, Lin KMC. Assessment of Polyethylene Glycol-Coated Gold Nanoparticle Toxicity and Inflammation In Vivo Using NF-κB Reporter Mice. Int J Mol Sci 2020; 21:ijms21218158. [PMID: 33142808 PMCID: PMC7662512 DOI: 10.3390/ijms21218158] [Citation(s) in RCA: 13] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2020] [Revised: 10/23/2020] [Accepted: 10/27/2020] [Indexed: 12/13/2022] Open
Abstract
Polyethylene glycol (PEG) coating of gold nanoparticles (AuNPs) improves AuNP distribution via blood circulation. The use of PEG-coated AuNPs was shown to result in acute injuries to the liver, kidney, and spleen, but long-term toxicity has not been well studied. In this study, we investigated reporter induction for up to 90 days in NF-κB transgenic reporter mice following intravenous injection of PEG-coated AuNPs. The results of different doses (1 and 4 μg AuNPs per gram of body weight), particle sizes (13 nm and 30 nm), and PEG surfaces (methoxyl- or carboxymethyl-PEG 5 kDa) were compared. The data showed up to 7-fold NF-κB reporter induction in mouse liver from 3 h to 7 d post PEG-AuNP injection compared to saline-injected control mice, and gradual reduction to a level similar to control by 90 days. Agglomerates of PEG-AuNPs were detected in liver Kupffer cells, but neither gross pathological abnormality in liver sections nor increased activity of liver enzymes were found at 90 days. Injection of PEG-AuNPs led to an increase in collagen in liver sections and elevated total serum cholesterol, although still within the normal range, suggesting that inflammation resulted in mild fibrosis and affected hepatic function. Administrating PEG-AuNPs inevitably results in nanoparticles entrapped in the liver; thus, further investigation is required to fully assess the long-term impacts by PEG-AuNPs on liver health.
Collapse
Affiliation(s)
- Tzu-Yin Chen
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Mei-Ru Chen
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Shan-Wen Liu
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
- Institute of Population Health, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan
| | - Jin-Yan Lin
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Ya-Ting Yang
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Hsin-Ying Huang
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Jen-Kun Chen
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Chung-Shi Yang
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
| | - Kurt Ming-Chao Lin
- Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes, Zhunan, Miaoli 35053, Taiwan; (T.-Y.C.); (M.-R.C.); (S.-W.L.); (J.-Y.L.); (Y.-T.Y.); (H.-Y.H.); (J.-K.C.); (C.-S.Y.)
- Correspondence: ; Tel.: +886-37206166-37118
| |
Collapse
|
|
6
|
Coughlin BP, Mace CR, Sykes ECH. Opportunities in the Synthesis and Design of Radioactive Thin Films and Nanoparticles. J Phys Chem Lett 2020; 11:4017-4028. [PMID: 32330038 DOI: 10.1021/acs.jpclett.0c00412] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/11/2023]
Abstract
Studies of radioactive isotopes at the liquid-solid or gas-solid interface are enabling a detailed mechanistic understanding of the effects of radioactive decay on physical, biological, and chemical systems. In recent years, there has been a burgeoning interest in using radioactive isotopes for both imaging and therapeutic purposes by attaching them to the surface of colloidal nanoparticles. By merging the field of nanomedicine with the more mature field of internal radiation therapy, researchers are discovering new ways to diagnose and treat cancer. In this Perspective, we discuss state-of-the-art radioactive thin films as applied to both well-defined surfaces and more complex nanoparticles. We highlight the design considerations that are unique to radioactive films, which originate from the damaging and potentially self-destructive emissions produced during radioactive decay, and highlight future opportunities in the largely underexplored area between radioisotope chemistry and nanoscience.
Collapse
Affiliation(s)
- Benjamin P Coughlin
- Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States
| | - Charles R Mace
- Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States
| | - E Charles H Sykes
- Department of Chemistry, Tufts University, Medford, Massachusetts 02155, United States
| |
Collapse
|
|
7
|
The Basic Properties of Gold Nanoparticles and their Applications in Tumor Diagnosis and Treatment. Int J Mol Sci 2020; 21:ijms21072480. [PMID: 32260051 PMCID: PMC7178173 DOI: 10.3390/ijms21072480] [Citation(s) in RCA: 120] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2020] [Revised: 03/29/2020] [Accepted: 04/01/2020] [Indexed: 12/14/2022] Open
Abstract
Gold nanoparticles (AuNPs) have been widely studied and applied in the field of tumor diagnosis and treatment because of their special fundamental properties. In order to make AuNPs more suitable for tumor diagnosis and treatment, their natural properties and the interrelationships between these properties should be systematically and profoundly understood. The natural properties of AuNPs were discussed from two aspects: physical and chemical. Among the physical properties of AuNPs, localized surface plasmon resonance (LSPR), radioactivity and high X-ray absorption coefficient are widely used in the diagnosis and treatment of tumors. As an advantage over many other nanoparticles in chemicals, AuNPs can form stable chemical bonds with S-and N-containing groups. This allows AuNPs to attach to a wide variety of organic ligands or polymers with a specific function. These surface modifications endow AuNPs with outstanding biocompatibility, targeting and drug delivery capabilities. In this review, we systematically summarized the physicochemical properties of AuNPs and their intrinsic relationships. Then the latest research advancements and the developments of basic research and clinical trials using these properties are summarized. Further, the difficulties to be overcome and possible solutions in the process from basic laboratory research to clinical application are discussed. Finally, the possibility of applying the results to clinical trials was estimated. We hope to provide a reference for peer researchers to better utilize the excellent physicochemical properties of gold nanoparticles in oncotherapy.
Collapse
|
|
8
|
Laprise-Pelletier M, Simão T, Fortin MA. Gold Nanoparticles in Radiotherapy and Recent Progress in Nanobrachytherapy. Adv Healthc Mater 2018; 7:e1701460. [PMID: 29726118 DOI: 10.1002/adhm.201701460] [Citation(s) in RCA: 65] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/15/2017] [Revised: 03/07/2018] [Indexed: 12/29/2022]
Abstract
Over the last few decades, gold nanoparticles (GNPs) have emerged as "radiosensitizers" in oncology. Radiosensitizers are additives that can enhance the effects of radiation on biological tissues treated with radiotherapy. The interaction of photons with GNPs leads to the emission of low-energy and short-range secondary electrons, which in turn increase the dose deposited in tissues. In this context, GNPs are the subject of intensive theoretical and experimental studies aiming at optimizing the parameters leading to greater dose enhancement and highest therapeutic effect. This review describes the main mechanisms occurring between photons and GNPs that lead to dose enhancement. The outcome of theoretical simulations of the interactions between GNPs and photons is presented. Finally, the findings of the most recent in vivo studies about interactions between GNPs and photon sources (e.g., external beams, brachytherapy sources, and molecules labeled with radioisotopes) are described. The advantages and challenges inherent to each of these approaches are discussed. Future directions, providing new guidelines for the successful translation of GNPs into clinical applications, are also highlighted.
Collapse
Affiliation(s)
- Myriam Laprise-Pelletier
- Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CR-CHU de Québec); Axe Médecine Régénératrice; Québec G1L 3L5 QC Canada
- Department of Mining; Metallurgy and Materials Engineering; Université Laval; Québec G1V 0A6 QC Canada
- Centre de Recherche sur les Matériaux Avancés (CERMA); Université Laval; Québec G1V 0A6 QC Canada
| | - Teresa Simão
- Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CR-CHU de Québec); Axe Médecine Régénératrice; Québec G1L 3L5 QC Canada
- Department of Mining; Metallurgy and Materials Engineering; Université Laval; Québec G1V 0A6 QC Canada
- Centre de Recherche sur les Matériaux Avancés (CERMA); Université Laval; Québec G1V 0A6 QC Canada
| | - Marc-André Fortin
- Centre de Recherche du Centre Hospitalier Universitaire de Québec-Université Laval (CR-CHU de Québec); Axe Médecine Régénératrice; Québec G1L 3L5 QC Canada
- Department of Mining; Metallurgy and Materials Engineering; Université Laval; Québec G1V 0A6 QC Canada
- Centre de Recherche sur les Matériaux Avancés (CERMA); Université Laval; Québec G1V 0A6 QC Canada
| |
Collapse
|
|
9
|
Cui L, Her S, Borst GR, Bristow RG, Jaffray DA, Allen C. Radiosensitization by gold nanoparticles: Will they ever make it to the clinic? Radiother Oncol 2017; 124:344-356. [PMID: 28784439 DOI: 10.1016/j.radonc.2017.07.007] [Citation(s) in RCA: 96] [Impact Index Per Article: 13.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2016] [Revised: 06/29/2017] [Accepted: 07/05/2017] [Indexed: 12/14/2022]
Abstract
The utilization of gold nanoparticles (AuNPs) as radiosensitizers has shown great promise in pre-clinical research. In the current review, the physical, chemical, and biological pathways via which AuNPs enhance the effects of radiation are presented and discussed. In particular, the impact of AuNPs on the 5 Rs in radiobiology, namely repair, reoxygenation, redistribution, repopulation, and intrinsic radiosensitivity, which determine the extent of radiation enhancement effects are elucidated. Key findings from previous studies are outlined. In addition, crucial parameters including the physicochemical properties of AuNPs, route of administration, dosing schedule of AuNPs and irradiation, as well as type of radiation therapy, are highlighted; the optimal selection and combination of these parameters enable the achievement of a greater therapeutic window for AuNP sensitized radiotherapy. Future directions are put forward as a means to provide guidelines for successful translation of AuNPs to clinical applications as radiosensitizers.
Collapse
Affiliation(s)
- Lei Cui
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
| | - Sohyoung Her
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada
| | - Gerben R Borst
- Department of Radiation Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands
| | - Robert G Bristow
- Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Canada; Ontario Cancer Institute/Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
| | - David A Jaffray
- Departments of Radiation Oncology and Medical Biophysics, University of Toronto, Canada; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; TECHNA Institute and Department of Radiation Physics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Department of Radiation Physics, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Techna Institute, University Health Network, Toronto, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada
| | - Christine Allen
- Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada; STTARR Innovation Centre, Radiation Medicine Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Canada.
| |
Collapse
|
|
10
|
Yin Y, Tan Z, Hu L, Yu S, Liu J, Jiang G. Isotope Tracers To Study the Environmental Fate and Bioaccumulation of Metal-Containing Engineered Nanoparticles: Techniques and Applications. Chem Rev 2017; 117:4462-4487. [PMID: 28212026 DOI: 10.1021/acs.chemrev.6b00693] [Citation(s) in RCA: 43] [Impact Index Per Article: 6.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The rapidly growing applicability of metal-containing engineered nanoparticles (MENPs) has made their environmental fate, biouptake, and transformation important research topics. However, considering the relatively low concentration of MENPs and the high concentration of background metals in the environment and in organisms, tracking the fate of MENPs in environment-related scenarios remains a challenge. Intrinsic labeling of MENPs with radioactive or stable isotopes is a useful tool for the highly sensitive and selective detection of MENPs in the environment and organisms, thus enabling tracing of their transformation, uptake, distribution, and clearance. In this review, we focus on radioactive/stable isotope labeling of MENPs for their environmental and biological tracing. We summarize the advantages of intrinsic radioactive/stable isotopes for MENP labeling and discuss the considerations in labeling isotope selection and preparation of labeled MENPs, as well as exposure routes and detection of labeled MENPs. In addition, current practice in the use of radioactive/stable isotope labeling of MENPs to study their environmental fate and bioaccumulation is reviewed. Future perspectives and potential applications are also discussed, including imaging techniques for radioactive- and stable-isotope-labeled MENPs, hyphenated multistable isotope tracers with speciation analysis, and isotope fractionation as a MENP tracer. It is expected that this critical review could provide the necessary background information to further advance the applications of isotope tracers to study the environmental fate and bioaccumulation of MENPs.
Collapse
Affiliation(s)
- Yongguang Yin
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China.,Institute of Environment and Health, Jianghan University , Wuhan 430056, China
| | - Zhiqiang Tan
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China
| | - Ligang Hu
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China
| | - Sujuan Yu
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China
| | - Jingfu Liu
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China
| | - Guibin Jiang
- State Key Laboratory of Environmental Chemistry and Ecotoxicology, Research Center for Eco-Environmental Sciences, Chinese Academy of Sciences , Beijing 100085, China
| |
Collapse
|
|
11
|
Lai SF, Ko BH, Chien CC, Chang CJ, Yang SM, Chen HH, Petibois C, Hueng DY, Ka SM, Chen A, Margaritondo G, Hwu Y. Gold nanoparticles as multimodality imaging agents for brain gliomas. J Nanobiotechnology 2015; 13:85. [PMID: 26589283 PMCID: PMC4654925 DOI: 10.1186/s12951-015-0140-2] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Accepted: 10/22/2015] [Indexed: 11/20/2022] Open
Abstract
Background Nanoparticles can be used for targeted drug delivery, in particular for brain cancer therapy. However, this requires a detailed analysis of nanoparticles from the associated microvasculature to the tumor, not easy because of the required high spatial resolution. The objective of this study is to demonstrate an experimental solution of this problem, based in vivo and post-mortem whole organ imaging plus nanoscale 3-dimensional (3D) X-ray microscopy. Results The use of gold nanoparticles (AuNPs) as contrast agents paved the way to a detailed high-resolution three dimensional (3D) X-ray and fluorescence imaging analysis of the relation between xenografted glioma cells and the tumor-induced angiogenic microvasculature. The images of the angiogenic microvessels revealed nanoparticle leakage. Complementary tests showed that after endocytotic internalization fluorescent AuNPs allow the visible-light detection of cells. Conclusions AuNP-loading of cells could be extended from the case presented here to other imaging techniques. In our study, they enabled us to (1) identify primary glioma cells at inoculation sites in mice brains; (2) follow the subsequent development of gliomas. (3) Detect the full details of the tumor-related microvasculature; (4) Finding leakage of AuNPs from the tumor-related vasculature, in contrast to no leakage from normal vasculature. Electronic supplementary material The online version of this article (doi:10.1186/s12951-015-0140-2) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Sheng-Feng Lai
- Department of Engineering Science, National Cheng Kung University, Tainan, 701, Taiwan.
| | - Bai-Hung Ko
- Department of Engineering Science, National Cheng Kung University, Tainan, 701, Taiwan. .,Institute of Physics, Academia Sinica, Nankang, Taipei, 115, Taiwan.
| | - Chia-Chi Chien
- Institute of Physics, Academia Sinica, Nankang, Taipei, 115, Taiwan.
| | - Chia-Ju Chang
- Institute of Physics, Academia Sinica, Nankang, Taipei, 115, Taiwan.
| | - Shun-Ming Yang
- Institute of Physics, Academia Sinica, Nankang, Taipei, 115, Taiwan.
| | - Hsiang-Hsin Chen
- Inserm U1029 LMMA, University of Bordeaux, 33600, Pessac Cedex, France.
| | - Cyril Petibois
- Inserm U1029 LMMA, University of Bordeaux, 33600, Pessac Cedex, France.
| | - Dueng-Yuan Hueng
- Department of Biochemistry, School of Medicine, National Defense Medical Center, Taipei, 114, Taiwan. .,Department of Neurological Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
| | - Shuk-Man Ka
- Institute of Aerospace and Undersea Medicine, School of Medicine, National Defense Medical Center, Taipei, 114, Taiwan.
| | - Ann Chen
- Department of Pathology, Tri-Service General Hospital, National Defense Medical Center, Taipei, 114, Taiwan.
| | - G Margaritondo
- School of Basic Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015, Lausanne, Switzerland.
| | - Y Hwu
- Department of Engineering Science, National Cheng Kung University, Tainan, 701, Taiwan. .,Institute of Physics, Academia Sinica, Nankang, Taipei, 115, Taiwan. .,Advanced Optoelectronic Technology Center, National Cheng Kung University, Tainan, 701, Taiwan.
| |
Collapse
|